Pradaxa
Pradaxa Antidote Does Not Eliminate Bleeding Risks
Pradaxa Antidote, Praxbind, Only Available in Hospitals. The bleeding risks associated with Pradaxa (dabigatran etexilate) are fairly well known in the United States following a number of serious injury reports and deaths. Pradaxa was approved by the U.S. Food and Drug Administration (FDA) in 2010 and is manufactured by drug maker … [Read more...] about Pradaxa Antidote Does Not Eliminate Bleeding Risks
Pradaxa Patients Face Bleeding Risks Despite Antidote
Pradaxa Patients Face Bleeding Risks Despite Antidote. The bleeding risk for people taking the blood-thinning drug Pradaxa is well documented, and the risk persists despite a recently developed bleeding antidote. Many patients allege that the drug maker was reckless in introducing Pradaxa to the market with a bleeding … [Read more...] about Pradaxa Patients Face Bleeding Risks Despite Antidote
Pradaxa Traumatic Trauma Bleeding Hemorrhaging Lawsuit
Pradaxa Traumatic Bleeding Injury Lawsuits. Pradaxa patients who have suffered minor traumas, including falls, have experienced serious, life-threatening traumatic hemorrhages, including brain bleeds. In some cases, trauma patients taking Pradaxa who were admitted to the ER following a seemingly minor head injury have died … [Read more...] about Pradaxa Traumatic Trauma Bleeding Hemorrhaging Lawsuit
Pradaxa Bleeding Following Atrial Fibrillation Ablation
Pradaxa Bleeding Risk. Did you suffer severe Pradaxa bleeding or Pradaxa hemorrhaging following radiofrequency ablation to treat atrial fibrillation? A study published in February 2012 found that patients treated with Pradaxa following atrial fibrillation ablation had higher rates of bleeding and hemorrhaging compared to … [Read more...] about Pradaxa Bleeding Following Atrial Fibrillation Ablation
Pradaxa Safety Questioned
Plaintiffs Allege Pradaxa Related Injuries. Plaintiffs in the Pradaxa litigation are calling into question whether or not the blood thinner is safe. Pradaxa, known generically as dabigatran, is manufactured by Boehringer Ingelheim to reduce the risk of blood clots and related injuries, such as stroke and pulmonary embolism, in … [Read more...] about Pradaxa Safety Questioned
BMJ Criticizes Pradaxa’s Approval Process
BMJ Criticizes Pradaxa’s Approval Process. Pradaxa (dabigatran), an anticoagulant manufactured by Boehringer Ingelheim, has been the subject of safety concerns in the short time that it has been on the market. Now, four reports published in the British Medical Journal (BMJ) criticize the way Pradaxa was approved, stating … [Read more...] about BMJ Criticizes Pradaxa’s Approval Process
Pradaxa Viral Infection Risks
Pradaxa Risks Of Viral Infections. An emerging study reveals that the blood thinner Pradaxa (dabigatran etexilate mesylate) may increase the risks for, and severity of, viral infections. In recent months, Pradaxa also has been linked to injuries and deaths related to uncontrollable bleeding. University of North … [Read more...] about Pradaxa Viral Infection Risks
Europe Regulator Addresses Pradaxa Bleeding Deaths
Europe Regulator Addresses Pradaxa Bleeding Deaths However, the European Medicines Agency (EMA) said that new prescribing recommendations issued last week would mitigate the Pradaxa bleeding risk. Those recommendations advised doctors to subject Pradaxa patients older than 75, as well as those with renal impairment, to annual … [Read more...] about Europe Regulator Addresses Pradaxa Bleeding Deaths
Potential Risks of Using Pradaxa
Potential Risks Of Using Pradaxa. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, is recognizing Atrial Fibrillation Awareness Month by warning that Boehringer Ingelheim’s Pradaxa is allegedly associated with potentially fatal hemorrhages. According to the National … [Read more...] about Potential Risks of Using Pradaxa
Pradaxa Bleeding Lawsuits Moving Forward
In less than a month, more than 50 cases have been added to the newly-formed Pradaxa Multidistrict Litigation that claims the blood thinner Pradaxa (dabigatran) causes serious and fatal gastrointestinal bleeding and cerebral hemorrhaging and is no safer or more effective than its predecessor. According to a report from The Madison … [Read more...] about Pradaxa Bleeding Lawsuits Moving Forward
Pradaxa Lawsuits Consolidated
Pradaxa Lawsuits Consolidated. Today all Pradaxa lawsuits filed in federal district courts throughout the United States will be consolidated before Judge David Herndon in the Southern District of Illinois. In choosing Judge Herndon to preside over the Pradaxa litigation, the U.S. Judicial Panel on Multidistrict Litigation cited … [Read more...] about Pradaxa Lawsuits Consolidated
Pradaxa Bleeding Lawsuits MDL
Pradaxa Bleeding Lawsuits Heading For Multidistrict Litigation. Word on whether Pradaxa bleeding lawsuits will be consolidated in a multidistrict litigation should come later this month or early. According to a report from The Madison Record, the Judicial Panel on Multidistrict Litigation will hold a hearing July 26 on a motion to … [Read more...] about Pradaxa Bleeding Lawsuits MDL
New Pradaxa Bleeding Side Effect Guidance
Pradaxa Is Recommended To Update New Label Regarding The Bleeding Side Effects European regulators have completed another Pradaxa review, and are recommending that the blood thinner’s label be updated with new safety information regarding Pradaxa bleeding side effects. The European Medicines Agency's Committee for Medicinal … [Read more...] about New Pradaxa Bleeding Side Effect Guidance
ISMP Details More Pradaxa Bleeding Reports
More bad news this week for Pradaxa. According to the latest QuarterWatch report from the Institute for Safe Medicine Practices (ISMP), Pradaxa was associated with a total 856 reports of serious, disabling or fatal injury in the second quarter of 2011. Of those, 117 involved deaths that could be associated with serious Pradaxa … [Read more...] about ISMP Details More Pradaxa Bleeding Reports
Pradaxa Traumatic Bleeding Dangers
Pradaxa Traumatic Bleeding Risk. A case study published earlier this in the Journal of Neurosurgery highlighted the risk elderly Pradaxa patients could face from only a minor trauma. The report detailed the death of an 83-year-old Pradaxa patient from a traumatic brain bleed that followed a minor fall. The report is disturbing … [Read more...] about Pradaxa Traumatic Bleeding Dangers
Bleeding Reports Prompt Pradaxa Label Changes
Pradaxa Add New Warnings To Its Label. Reports of Pradaxa bleeding side effects have prompted regulators in Canada - where it is sold as Pradax - to add new warnings to its label regarding use of the drug in kidney patients. New information will also be added to address use of Pradaxa in patients with severe valvular disease or … [Read more...] about Bleeding Reports Prompt Pradaxa Label Changes
Pradaxa Linked to Bleeding Deaths
Bleeding Deaths Linked To Pradaxa. Since its launch last year, roughly 50 Pradaxa patients worldwide have died as a result of bleeding. Bloomberg News, quoting the German newspaper Die Zeit, reported that Boehringer Ingelheim is investigating the deaths. Pradaxa is approved to prevent strokes in people with atrial fibrillation. … [Read more...] about Pradaxa Linked to Bleeding Deaths
Pradaxa Adverse Event Reports to FDA
Red Flag Raised About Pradaxa. A drug monitoring group is raising yet another red flag about Pradaxa. According to the Institute for Safe Medication Practices (ISMP), since its October 2010, Pradaxa has been named in more U.S. Food & Drug Administration (FDA) Adverse Event Reports than more than 98% of the medications the group … [Read more...] about Pradaxa Adverse Event Reports to FDA
